关于在患有心血管疾病高风险的患者中使用罗莫苏祖马布的考虑因素
1Oregon Osteoporosis Center, Portland, OR.
概括
罗莫苏祖马布提供优越的骨质疏松症治疗方法,但具有心血管风险. 本综述有助于临床医生平衡骨效益与高风险患者的潜在心血管风险.
科学领域:
- 内分泌学 在内分泌学.
- 心脏病学 心脏病学
- 老年病的医生 老年病的医生
背景情况:
- 脊椎骨折的老年患者骨质疏松症的管理.
- 罗莫苏祖马布对心血管疾病 (CV 风险) 的疗效和禁忌.
- 患者简介:74岁的女性脊椎骨折,高血压和高脂血症,表明心血管风险高.
研究的目的:
- 审查Romosozumab心血管风险禁忌的背景.
- 检查近期关于罗莫苏祖马布和心血管风险的现实证据.
- 支持在患有心血管风险因素的患者中对Romosozumab的临床决策.
主要方法:
- 关于Romosozumab的研究的文献综述.
- 对心血管风险因素和计算器的分析.
- 关于Romosozumab对心血管风险的疗效的综合证据.
主要成果:
- 与其他疗法相比,罗莫苏祖马布在治疗骨质疏松症方面表现出更高的疗效.
- 患者有多种风险因素,使她面临心血管事件的高风险.
- 在治疗决策中,平衡骨效益与潜在的心血管风险至关重要.
结论:
- 在CV风险非常高的患者中,Romosozumab是禁忌的.
- 临床医生必须仔细权衡Romosozumab的益处与其在特定患者的潜在心血管风险.
- 在高风险人群中对骨质疏松症的管理中,了解患者和提供者的讨论是必不可少的.
更多相关视频
06:04Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
1.4K
07:20Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice
Published on: August 23, 2024
1.0K
相关概念视频
Coronary Artery Disease IV: Preventive Measures
579
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
579
Rheumatic Heart Disease III: Medical Management
277
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
277
Atherosclerosis III: Management
311
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
311
Cardiovascular Drugs: Classification based on Therapeutic Indications
4.0K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.0K
Rheumatic Heart Disease IV: Nursing Management
260
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
260
Coronary Artery Disease III: Clinical Manifestations
314
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
314
